Assignee
ENGMAB AG
CH·3 granted patents·4 pending applications·35 citations·filing 2014–2015
Top patents by PatentIndex Score
7 records- 0192US9963513B2Method for the selection of antibodies against BCMAENGMAB AG·Filed 2014·Granted May 8, 2018·19 cites·5 claims
- 0287US10253104B2Bispecific antibodies against CD3ϵ and BCMAENGMAB AG·Filed 2015·Granted Apr 9, 2019·10 cites·16 claims
- 0384US10077315B2Bispecific antibodies against CD3 and BCMAENGMAB AG·Filed 2014·Granted Sep 18, 2018·6 cites·5 claims
- 0450US2016297881A1BISPECIFIC ANTIBODIES AGAINST CD3EPSILON and ROR1ENGMAB AG·Filed 2014·Application pending·0 cites
- 0542US2017327580A1Bispecific antibodies against cd3 epsilon and bcma for use in treatment of diseasesENGMAB AG·Filed 2015·Application pending·0 cites
- 0634US2017327579A1Bispecific antibodies against cd3epsilon and bcmaENGMAB AG·Filed 2015·Application pending·0 cites
- 0733US2017306044A1Bispecific antibodies against cd3epsilon and ror1 for use in the treatment of ovarian cancerENGMAB AG·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →